Gene, cell therapy fund-raising set to outpace 2017 total

Gene and cell therapy companies have raised $2.3 billion in equity in 2018 as of the end of last week, according to BioCentury’s BCIQ database. The figure is more than half of the $4.5 billion raised in all of 2017.

Gene and cell therapies companies’ annual fund-raising totals have increased each year since 2008. The biggest jump was in 2015, when equity raised jumped to $3.3 billion from $1.6 billion in 2014...